2[1]Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ,1995,311 (7010)∶899-909.
3[2]Le Chevalier T, for the IALT Investigators. Results of the Randomized International Adjuvant Lung Cancer (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients with resected non-small cell lung cancer. Proc Am Soc Clin Oncol,2003∶A6.
4[3]PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer ( Cochrane Review ) [J/CD]. Issue 1. Oxford: The Cochrane Library, 2001. Update Software.
5[4]Kato H, Tsuboi M, Ohta M, et al. A randomized phase Ⅲ trial of adjuvant chemotherapy with UFT for completely resected pathological stage Ⅰ (T1N0M0,T2N0M0) adenocarcinoma of the lung. Proc Am Soc Clin Oncol,2003,23∶2498a.
6[5]Albain KS, Scott CB, Rush VR, et al. Phase Ⅲ comparison of concurrent chemotherapy plus radiotherapy ( CT/RT) and CT/RT followed by surgical resection for stage ⅢA (PN2) non-small-cell lung cancer (NSCLC): Initial results from intergroup trial 0139(RTOG93-09). Proc Am Soc Clin Oncol,2003, 22∶621(A#2497).
7[7]Zhou QH(周清华), Liu LX, Li L, et al. A randomized clinical trial of preoperative neoadjuvant chemotherapy followed by surgery in the treatment of stage Ⅲ non-small cell lung cancer. Lung Cancer, 2003,41(S2)∶S45-S46.
4Hrbacek J.Dosimetric comparison of flattened and unflattened beamsfor stereotactic ablative radiotherapy of stage I non-small cell lungcancer[J].Med Phys,2014,41(3):9-10.
5Zhang X.Expression of HMGB1 and NF-κB p65 and its significancein non-small cell lung cancer[J]. Contemp Oncol(Pozn),2013,17(4):350-355.
6Sebastian M.First-line treatment of EGFR-mutated nonsmall cell lungcancer:critical review on study methodology[J].Eur Respir Rev,2014,23(131):92-105.
7Takahashi W.Carbon ion radiotherapy in a hypofractionation regimen forstage I non-small-cell lung cancer[J].J Radiat Res,2014,55(1):26-27.
8Moloney F.Increasing the accuracy of 18 F-FDG PET/CT interpreta-tion of “mildly positive” mediastinal nodes in the staging of non-smallcell lung cancer[J].Eur J Radiol,2014,28(14):34-35.
